glp-1 receptor antagonist Emerging Nondopaminergic Medications for Parkinson's Disease: Focusing on A2A Antagonists and GLP1 Receptor Agonists Endogenous Activation of Glucagon-Like Peptide-1
Pay in 4 interest-free payments of $7.32 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5



























